Maryanna Saenko

Forest Investments, Inc. is a holding company, which engages in the investment and acquisition of businesses, securities and assets that has significant long-term value creation. It operates through the following segments: Durable Medical Equipment, Investment Management, Real Estate, and General Corporate. The company was founded on December 16, 1994 and is headquartered in Waltham, MA.

Mitel Communications AB provides enterprise mobility and converged communication software solutions. The firm is an innovative software vendor enabling any type of service provider to offer advanced business communication as a service under its own brands. Its solution helps service providers drive revenue, loyalty and margin by allowing enterprises to transform the way they communicate. The company was founded by Jörgen Björkner and Lars-Michaël Paqvalén in 2003 and is headquartered in Stockholm, Sweden.

Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA.

The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA.

Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.

Part of Accel Partners LLC, Accel Partners & Co., Inc. is a venture capital firm.

Khosla Ventures LLC (Khosla Ventures) is a venture capital firm founded in 2004 by Vinod Khosla. The firm is headquartered in Menlo Park, California.

Part of Nokia Oyj, Nokia Unterhaltungselektronik GmbH is a German company that manufactures consumer electronics. The company is based in Pforzheim, Germany.

Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.

Momio ApS develops, markets and operates entertainment and gaming websites. Its products include Momio, which is a social media application for kids where users can send free messages, post texts, pictures and videos. The company was founded by Henrik Riis, Thomas Laurfelt and Lars Engholm Johansen in 2004 and is headquartered in Lisbon, Portugal.

GetJar Networks Ltd. develops mobile applications. It operates an open mobile application store content directly to consumers. The company was founded on August 22, 2007 and is headquartered in Crowthorne, the United Kingdom.

Marshall Group AB provides headphones and speakers. The company was founded by Markus Rudback, Kenneth Schonborg, Niklas Bergh, Konrad Bergstrom, Oscar Axhede, Andreas Enquist, Vincent Skoglund and Erik Peterson in 2008 and is headquartered in Stockholm, Sweden.

Zenterio AB is a software company, which engages in the provision of an independent operating systems for interactive television. It also offers cloud-based solutions for content aggregation, data and analytics, home automation integrations, and advertising capabilities. The company was founded by Kent Lundberg in 1996 and is headquartered in Linkoping, Sweden.

Part of Amicus Therapeutics, Inc., Amicus Therapeutics UK Ltd. is a company that focuses on delivering high-quality therapies for persons living with rare and orphan diseases. The company is based in Gerrards Cross, UK. The employees of Amicus crafted a belief statement that encompasses their core values and reminds them of the reason they do what they do every day. The statement outlines the fundamental beliefs that are crucial to understanding the passion and commitment behind Amicus. The British company believes in the fight to remain at the forefront of therapies for rare and orphan diseases, supporting the disease communities and their families, and fostering teamwork and respect for each individual's contribution.

F-Star Beta Ltd. is a biopharmaceutical company that focused in the development of oncology and immune-oncology products. The company was founded on October 14, 2014 and is headquartered in Cambridge, the United Kingdom.

Part of Sino Biopharmaceutical Ltd., F-Star Delta Ltd. develops antibody products to improve the treatment of serious diseases. The company is based in Cambridge, UK and was founded in 2016.

EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham.

Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then.

Part of Johnson & Johnson, Anakuria Therapeutics, Inc. is a biotechnology company that develops therapies for kidney disease. The company is based in Cambridge, MA. Anakuria Therapeutics was acquired by Janssen Pharmaceuticals, Inc. from Navitor Pharmaceuticals, Inc. on February 02, 2022.

Liberate Bio, Inc. develops novel genetic medicines. The company is based in Boston, MA. The company was founded by Michael Mitchell, Nessan Bermingham, Stephen Scully, Theresa M. Reineke. The CEO is Shawn Davis.